Ulcerative Colitis Clinical Trials

Showing 7161-7180 of 7,290 trials

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144482

To evaluate the effectiveness and safety in randomized, double-blind, parallel-group study in anemic cancer patients undergoing chemotherapy

Chemotherapy Induced Anemia

Chugai Pharmaceutical122 participantsStarted Dec 2003

TERMINATEDNA

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

NCT00586807

The metabolic response to ulcerative colitis, including increased proteolysis and lipolysis and changes in energy expenditure, plays a significant role in the resulting malnutrition from which these patients suffer. Tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine, has been found to be elevated in children with ulcerative colitis. TNF-alpha has been incriminated in the mechanism of weight loss in many different chronic diseases, and causes net protein and lipid catabolism. Anti-TNF-alpha antibody (infliximab) has been proven to be an effective therapy for ulcerative colitis. The purpose of this study is to determine changes in protein and lipid metabolism, as well as resting energy expenditure, before and after therapy with anti-TNF-alpha antibody (infliximab) in children with ulcerative colitis. Performing this study will better define the changes in nutrition status observed in these children following remission of active ulcerative colitis, and potentially lead to changes in medical and nutritional management of these children

Ulcerative ColitisProtein MetabolismEnergy Expenditure

Indiana University10 participantsStarted Jun 2005

Indianapolis, Indiana, United States

TERMINATEDPhase 1

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

NCT00621556

1. To assess the effect of RG1068 at a dose of 0.2 mcg/kg intravenously (IV) on the diameter of the pancreatic duct when used during Magnetic Resonance Pancreatography 2. To demonstrate that RG1068-enhanced MRCP improves detection and characterization of intraductal papillary mucinous neoplasms (IPMN) relative to unenhanced MRCP in patients with suspected IPMN 3. To correlate findings on MRCP with histologically confirmed malignancy

Intraductal Papillary Mucinous Neoplasms

Massachusetts General Hospital2 participantsStarted Feb 2008

Boston, Massachusetts, United States

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Related Searches

Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease

The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

Diclofenac vs Dexamethasone in Combined Surgery

Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects

Transforming Psychotherapy for Chronically Ill Patients

Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

Basiliximab in Moderate to Severe Ulcerative Colitis

Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community

Sleep at 30 Degrees in Glaucoma

Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)

Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)

Smoking Cessation in Patients With COPD (SMOCC) in General Practice

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Oral Zinc Therapy for the Prevention of Mucositis

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)

Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma